Cell Bio 3 Flashcards
(93 cards)
characteristics of ETOH
lipid and water soluble, absorbed in GI tract via passive diffusion –> metabolized in liver –> becomes acetaldehyde via alc dehydrogenase in cyto –> acetaldehyde to acetate via acetaldehyde dehydrogenase in mito –> NADH produced to go to ETC to make ATP
acetaldehyde vs acetate in blood
low levels in blood = fine, high chronic levels = bad b/c toxic intermediate (ROS) vs enters blood –> taken up by muscle and other tissues –> acetyl CoA go to TCA
acute vs chronic alc effects
inc NADH/NAD+ ratio (for q ETOH –> you make NADH) –> inhibits TCA –> FA catabolism to acetyl CoA –> excess acetyl CoA –> ketone bodies –> ketogenesis –> ketoacidosis; inc NADH –> inhibits FA [O] –> FA synthesis –> TAG –> VLDL –> hyperlipidemia; inc NADH –> pyru to lactate –> inhibits gluconeogenesis –> lactic acidosis, hypoglycemia; inc NADH –> inhibits glycolysis –> hyperglycemia. REVERSIBLE EFFECTS vs alc-induced liver dz, alc-induced hepatitis, hepatic steatosis aka fatty liver, cirrhosis, inc acetald and free radicals. IRREVERSIBLE EFFECTS
Class I alc dehydrogenase (ADH)
highest affinity to ETOH, located in liver, ETOH –> acetald + 1 NADH
ALDH I vs II
in cyto, picks up excess acetald vs in mito, [O] 80% of acetald to acetate and makes 1 NADH
Microsomal Ethanol Oxidizing System (MEOS)
[O] ETOH to acetald w/o making NADH in cyto –> make more ROS and acetald –> bad; binds to ETOH if [ETOH] = high; part of liver detox
cytochrome P450
can release more superoxide if induced by drugs, alc, chemical toxins (b/c superoxide can escape); O2 binds to Fe center and takes 1 e- from Fe –> superoxide binds w/ substrate
how much ATP = gained w/ ADH/ALDH vs MEOS?
12 ATP + 1 GTP per ETOH oxidized vs 7 ATP + 1 GTP
how can acetald dmg body?
bind to glutathionine –> cell loses primary defense mechanism; bind to free radical defense proteins –> inactivates them; dmgs ETC –> uncouples ETC from ATP synthase –> no FA [O] –> FA inc; dmg ALDH –> inc acetald levels (vicious cycle)
endogenous toxicants
toxic agents produced inside body, may be harmful as xenobiotics; caused by inborn error of metabolism (protein structure-fxn error d/t gene abnmllity)
liver detox has 2 phases
Phase I: [O], [H], or hydrolysis = bioactivation; carried out by cyt P450 mixed-fxn oxidases; prepares cmpds for phase II rxns
Phase II: conjugation w/ H2O soluble molec; specific rxns w/ specific enzymes; allows excretion via blood-kidney-urine or bile-feces
CYP2B1/2
phenobarbitol inc CYP2B2 –> ppl have dec sensitivity to phenobarbitol –> they take more. ethanol = inhibitor of CYP2B1/2 so if you take phenobarbitol + ethanol –> dec phenobarbitol metab –> high lvls of barbituates in blood
liver vs muscle w/ glycogen
controls blood glu lvl, can break down glycogen whenever vs keeps glycogen for its own use (not released in blood), lots of glycogen for fast twitch muscles
liver vs muscle w/ fasting
liver has 12-24hr glycogen supply during fasting, completely depleted post 30hrs; glycogen degraded to glu vs glycogen degraded to G1P to G6P for glycolysis –> muscle ctx and meet ATP demands
glycogen structure
branched glu polysacch (alpha1,4 w/ branched alpha1,6 q 8-10 residues); only has 1 reducing end and it’s attached to glycogenin protein, nonreducing end attaches to the glu; branching allows for tight packing of glu, rapid synth/degrad, mult enzymes working at same time
in glycolysis, glu = phosphorylated to G6P by hexokinase
PHOSPHORYLATED –> traps glu in cell
hexokinase vs glucokinase
in tissue (liver & skel muscle), higher affinity for glu –> do glycolysis even if [glu] = low vs in liver and pancreatic beta cells, lower affinity for glu –> do glycolysis when [glu] = high
glycogen degrad in liver vs muscle (specific process)
nor/epi or glucagon –> inc glycogenolysis –> activate glycogen phosphorylase and debranching enzyme –> G6Pase (only present in liver & kidney) deP G6P –> glu vs glycogen breaks down to G1P via glycogen phosphorylase –> G1P to G6P via phosphoglucosemutase –> G6P goes glycolysis to make ATP; AMP and nor/epi = big signal for glycogen degrad in fast twitch (glucagon does nothing)
debranching enzyme
4:4 transferase activity (break alpha1,4), or 1,6 glucosidase activity (break alpha1,6)
signal transduction by glucagon
operates via cAMP-directed phosphorylation cascade: glucagon receptor is G-protein-coupled –> activates adenylate cyclase –> cAMP prod –> cAMP binds to inactive PKA –> activates PKA –> PKA phosphorylates target proteins –> phosphorylates glycogen synthase => inactive –> stops glycogen synthesis OR phosphorylates glycogen phosphorylase => active –> starts glycogen breakdown
signal transduction by insulin
operates via tyrosine kinase activated phosphorylation cascade: insulin receptor autophosphorylates –> activates its kinase activity and phosphorylates targets –> phosphorylated targets activate phosphatase –> phosphatase dephosphorylates glycogen synthase –> start glycogen synthesis/stop glycogen breakdown
glycogen phosphorylase a vs glycogen phosphorylase b. glycogen synthase I/a vs glycogen synthase D/b
when glycogen phosphorylase = phosphorylated/active vs when glycogen phosphorylase = not phosphorylated/inactive. when glycogen synthase = not phosphorylated/active vs when glycogen synthase = phosphorylated/inactive
exer for glycogen degrad
muscle contraction –> ATP to ADP –> adenylate cyclase –> cAMP –> PKA –> phosphorylates glycogen phosphorylase –> glycogen breakdown
epinephrine on metab
signals for more glu need for brain, blood, muscle -> similar effects of glucagon. Epinephrine binds to β-adrenergic receptors (G couple protein receptor) or liver alpha receptors –> stimulates adenylate cyclase –> PKA activation –> glycogen degrad for more glu –> more ATP for quick rxn => f/light